Skip to main content
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2008 Oct 1;23(3):262–266. doi: 10.1007/s12291-008-0059-6

Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome

Sarama Saha 1, Chandan Sarkar 1,, Subhash Chandra Biswas 1,2, R Karim 1,3
PMCID: PMC3453448  PMID: 23105767

Abstract

Abnormal lipid profile is often found in women with Polycystic Ovary Syndrome. To assess the impact of abnormal lipid profile on atherosclerosis in young Polycystic Ovary Syndrome women, carotid intima-media thickness as judged by B-mode ultrasonography were done in 30 young (18–35 yrs) Polycystic Ovary Syndrome women and in similarly age-matched 30 apparently healthy controls. Compared to controls, young Polycystic Ovary Syndrome women had significantly elevated serum total cholesterol, triglyceride and LDL-C levels and carotid intima-media thickness. HDL-C level did not differ significantly between two groups of women. In Polycystic Ovary Syndrome women carotid intima-media thickness was positively correlated with serum total cholesterol, triglyceride and LDL-C and negatively correlated with serum HDL-C. Our study suggests that even young Polycystic Ovary Syndrome women are prone to atherosclerosis from early age.

Key words: Lipid Profile, Polycystic Ovary Syndrome, Carotid Intima-media thickness

Full Text

The Full Text of this article is available as a PDF (137.8 KB).

References

  • 1.Poretsky L. On the Paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endo Cr Rev. 1991;21:3–27. doi: 10.1210/edrv-12-1-3. [DOI] [PubMed] [Google Scholar]
  • 2.Dunaif A. Insulin resistance and the polycystic ovary syndrome. Am J Med. 1995;98(suppl1A):33S–39S. doi: 10.1016/S0002-9343(99)80057-6. [DOI] [PubMed] [Google Scholar]
  • 3.Takayama S., White M.F., Kahn C.R. Phorbol ester-induced serine phosphorylation of insulin receptor decreases its tyrosine kinase activity. J Biol Chem. 1988;263:3440–3447. [PubMed] [Google Scholar]
  • 4.Zhang L.H., Rodriguez H., Ohno S., Miller W.L. Serine phosphorylation of human P450c17 increases 17, 20 lyase activity: Implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA. 1995;92:10619–10623. doi: 10.1073/pnas.92.23.10619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Talbott E., Guzick D., Clerici A., Berga S., Detre K., Weimer K., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Asterioscler Thromb Vase Biol. 1995;15:821–827. doi: 10.1161/01.atv.15.7.821. [DOI] [PubMed] [Google Scholar]
  • 6.Tonstad S., Joakimsen O., Stensland-Bugge E., Leren T.P., Ose L., Russell D., et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996;16:984–991. doi: 10.1161/01.atv.16.8.984. [DOI] [PubMed] [Google Scholar]
  • 7.Salonen Jukka T., Solonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–1249. doi: 10.1161/01.atv.11.5.1245. [DOI] [PubMed] [Google Scholar]
  • 8.Guzick D.S., Talbott E.O., Sutton-Tyrrell K., Herzog H.C., Kuller L.H., Wolfson S.K., Jr. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol. 1996;174:1224–1229. doi: 10.1016/S0002-9378(96)70665-8. [DOI] [PubMed] [Google Scholar]
  • 9.Talbott E.O., Guzick D.S., Sutton-Tyrrell K., McHugh-Pemu K.P., Zborowski J.V., Remsberg K.E., et al. Evidence for association between Polycystic Ovary Syndrome and Premature Carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20:2414–2421. doi: 10.1161/01.atv.20.11.2414. [DOI] [PubMed] [Google Scholar]
  • 10.Allain C.C., Poon L.S., Chan C.S.G. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475. [PubMed] [Google Scholar]
  • 11.Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–482. [PubMed] [Google Scholar]
  • 12.Burstein M., Scholnick H.R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyamines. J Lipid Res. 1970;2:583–595. [PubMed] [Google Scholar]
  • 13.Friedwald W.T., Levy R.I., Friedrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]
  • 14.McAuley K.A., Williams S.M., Mann J.I., Walker R.J., Lewis-Barned N.J., Temple L.A., et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460–464. doi: 10.2337/diacare.24.3.460. [DOI] [PubMed] [Google Scholar]
  • 15.Galesanu C., Lisnic N., Teslaru R., Apostu L., Zbranca E. Lipid profile in a group of hypothyroid patients vs treated hypothyroid patients. Rev Med Chir Soc Med Nat Lasi. 2004;108:554–560. [PubMed] [Google Scholar]
  • 16.Heshmati H.M., Turpin G., deGennes J.L. Chronic hyperprolactinemia and plasma lipids in women. J Mol Med. 1987;65:516–519. doi: 10.1007/BF01721038. [DOI] [PubMed] [Google Scholar]
  • 17.Mattson L., Culberg G., Hamberger L., Samsioe G., Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril. 1984;42:579–584. doi: 10.1016/s0015-0282(16)48142-2. [DOI] [PubMed] [Google Scholar]
  • 18.Wild R., Painter P., Coulson P., Carruth K., Ranney G. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985;61:946–951. doi: 10.1210/jcem-61-5-946. [DOI] [PubMed] [Google Scholar]
  • 19.Talbott E., Clerici A., Berga S.L., Kuller L., Guzick D., Detre K., et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol. 1998;51:415–422. doi: 10.1016/S0895-4356(98)00010-9. [DOI] [PubMed] [Google Scholar]
  • 20.Bonithon-Kopp C., Scarabin P.-Y., Taquet A., Touboul P.-J., Kalmejac A., Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb. 1991;11:966–972. doi: 10.1161/01.atv.11.4.966. [DOI] [PubMed] [Google Scholar]
  • 21.Vryonidou A., Papatheoderou A., Tavridou A., Terzi T., Loi V., Vatalas I.A., et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2005;90:52740–52746. doi: 10.1210/jc.2004-2363. [DOI] [PubMed] [Google Scholar]
  • 22.Legro R.S., Finegood D., Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694–2698. doi: 10.1210/jc.83.8.2694. [DOI] [PubMed] [Google Scholar]
  • 23.Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113–121. doi: 10.1210/jcem-50-1-113. [DOI] [PubMed] [Google Scholar]
  • 24.Folsom A.R., Eckfeldt J.H., Majing W.S., Chambless L.E., Barnes R.W., Cram K.B. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size and physical activity. Stroke. 1994;25:66–73. doi: 10.1161/01.str.25.1.66. [DOI] [PubMed] [Google Scholar]
  • 25.Defronzo R.A., Ferrannini E. Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194. doi: 10.2337/diacare.14.3.173. [DOI] [PubMed] [Google Scholar]
  • 26.Wild S., Pierpoint T., McKeigue P., Jacobs H. Cardiovascular disease in women with PCOS at long-term follow-up; a retrospective cohort study. Clin Endocrinol. 2000;522:595–600. doi: 10.1046/j.1365-2265.2000.01000.x. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES